17 results found.

Traumatic Brain Injury, TBI, or ADHD Clinical Trial using Methylphenidate; Placebo

Children's Hospital Medical Center, Cincinnati - Recruiting 6 years to 17 years.
- Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI).
Methylphenidate; Placebo

Attention-deficit/Hyperactivity Disorder Clinical Trial using Methylphenidate (Concerta)

National Taiwan University Hospital - Recruiting 7 years to 16 years.
- A Study to Identify the Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in Attention Deficit Hyperactivity Disorder.
Methylphenidate (Concerta)

Attention Deficit Disorder With Hyperactivity, Attention Deficit Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years to 8 years.
- Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children.

Attention Deficit Disorder With Hyperactivity Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 3 years or older.
- The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder Clinical Trial using Computerized Progressive Attention Training; Sham Comparator Cognitive Training

Children's Hospital Medical Center, Cincinnati - Recruiting 7 years to 12 years.
- Efficacy of a Cognitive Training Intervention for Children With ADHD.
Computerized Progressive Attention Training; Sham Comparator Cognitive Training

Attention-deficit/Hyperactivity Disorder Clinical Trial using Lisdexamfetamine dimesylate; Methylphenidate Hydrochloride; Placebo

Shire Development LLC - Recruiting 13 years to 17 years.
- A Phase 4, Randomized, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 (VYVANSEr) Compared With OROS-MPH (CONCERTAr) With a Placebo Reference Arm, in Adolescents Aged 13-17 Years With Attention-deficit/Hyperactivity Disorder (ADHD).
Lisdexamfetamine dimesylate; Methylphenidate Hydrochloride; Placebo

Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial using AR11

Arbor Pharmaceuticals, Inc. - Recruiting 6 years to 12 years.
- A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom.
AR11

Attention-deficit/Hyperactivity Disorder Clinical Trial using Methylphenidate

Florida International University - Recruiting 6 years to 12 years.
- Examining Tolerance to CNS Stimulants in ADHD.
Methylphenidate

Attention Deficit Hyperactivity Disorder Clinical Trial using Ritalin; Placebo

McGill University - Recruiting 6 years to 12 years.
- .
Ritalin; Placebo

ADHD, or Attention Deficit Hyperactivity Disorder Clinical Trial using Naltrexone; Placebo

Massachusetts General Hospital - Recruiting 18 years to 55 years.
- A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder.
Naltrexone; Placebo

Attention-Deficit/Hyperactivity Disorder Clinical Trial using EMS 7500 Digital Muscle Stimulator

University of California, Los Angeles - Recruiting 9 years to 14 years.
- An Eight-Week, Open Trial Pilot Investigation of Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD).
EMS 7500 Digital Muscle Stimulator

Attention-Deficit Hyperactivity Disorder Clinical Trial using Cogmed Working Memory Training Program

University of Toronto - Recruiting 18 years to 35 years.
- Working Memory Training in Attention-Deficit/Hyperactivity Disorder: Neural Mechanisms of Change.
Cogmed Working Memory Training Program

Attention Deficit Disorder With Hyperactivity Clinical Trial using Valproate; Risperidone; Placebo; Stimulant medication; Behavioral family counseling

National Institute of Mental Health (NIMH) - Recruiting 6 years to 12 years.
- Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD.
Valproate; Risperidone; Placebo; Stimulant medication; Behavioral family counseling

ADHD, or Attention Clinical Trial using Cognitive training; Cognitive training-placebo

University of California, Davis - Recruiting 7 years to 14 years.
- Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder.
Cognitive training; Cognitive training-placebo

ADHD, St John`s Wort, Valerian Extract, Efficacy, or Safety Clinical Trial using St. John's Wort/Valerian Extract; Placebo

Johannes Gutenberg University Mainz - Recruiting 6 years to 17 years.
- Efficacy and Safety of St. John's Wort/Valerian Extract (Sedariston Concentrate) Versus Placebo in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD).
St. John's Wort/Valerian Extract; Placebo

Attention Disorder With Hyperactivity (ADHD) Clinical Trial

Hvolby, Allan, M.D. - Recruiting 5 years to 10 years.
- Sleep Disorders in Children With ADHD.